BioCheck acquires DRG

LabPulse.com staff writers
Aug 17, 2021
2020 03 25 23 27 0591 Hands Shaking Deal 400

BioCheck has acquired clinical diagnostic and research manufacturer DRG International, which manufactures clinical diagnostic and research enzyme-linked immunosorbent (ELISA) assays and has distributors in over 110 countries.

BioCheck plans to integrate its assay development capabilities with DRG's development center, IVD development, manufacturing, and sales channels. The company believes the combination will improve distribution of existing assays and speed up development of novel ELISAs and chemiluminescent immunoassay platforms.

The terms of the deal were not disclosed.

Latest in Collaboration
Pathology Digital Workstation Microscope Social
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
March 13, 2023
Lab Pathology Man Social
Pathology services provider PathGroup adopts Proscia digital platform
March 1, 2023
Bacteria Mycobacterium Tuberculosis Social
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
February 28, 2023
Scientists Pharmaceutical Laboratory Social
Omega Laboratories, Life Diagnostics to open drugs-of-abuse testing lab in UAE
February 21, 2023
Related Stories
2021 06 30 22 19 4138 Digital Science Lab 400
Collaboration
Lucid launches EsoGuard pilot test at centers in Ariz.
2019 04 26 21 48 5250 Money Hundred Bills 400
Collaboration
CAP to raise $2M to support cancer screening
2021 08 06 16 17 5155 Cancer Cell Microenvironment 400
Collaboration
Research finds tissue changes that may lead to cancer cells
2021 07 20 21 45 9618 Businessman Shake Hand Collegue 400
Collaboration
Lyniate wins contract from Diagnostic Support Services
More in Collaboration
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
Under the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.
March 13, 2023
Pathology Digital Workstation Microscope Social
Pathology services provider PathGroup adopts Proscia digital platform
PathGroup supports more than 15,000 referring physicians and more than 200 hospital customers with diversified laboratory testing services and customer service.
March 1, 2023
Lab Pathology Man Social
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Bacteria Mycobacterium Tuberculosis Social
Omega Laboratories, Life Diagnostics to open drugs-of-abuse testing lab in UAE
The laboratory will provide drugs-of-abuse testing in the Middle East/North Africa (MENA) region and incorporate Omega's toxicology experience and information technology solutions.
February 21, 2023
Scientists Pharmaceutical Laboratory Social
Quest Diagnostics, Tower Health ink multi-year testing agreement
Quest will support three hospitals within the Tower Health network: Reading Hospital; Phoenixville Hospital; and Pottstown Hospital in Pennsylvania.
February 16, 2023
Hands Shaking Deal Social
Cleveland Diagnostics, Quest Diagnostics expand access to blood-based prostate cancer test
When physicians order the IsoPSA prostate cancer test, their patients will provide blood specimens at a Quest patient service center. Quest will transport the blood samples for testing at a Cleveland Diagnostics’ laboratory.
February 13, 2023
Prostate Cancer Social
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Quest launches long-COVID testing panels for consumers
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
More in Collaboration
Siemens Healthineers, Unilabs ink 200-million euro agreement
In the first years of the agreement, Siemens Healthineers will install high- and mid-volume immunoassay and clinical chemistry analyzers, including the Atellica Solution and Atellica CI 1900, sample handlers, hemostasis analyzers, and automation solution
February 2, 2023
Scientists Pharmaceutical Laboratory Social
Genetic Technologies, Qiagen forming strategic alliance
Genetic Technologies said the alliance is expected to support the enhancement of its capabilities through software, hardware, consumable, and other technical solutions.
February 1, 2023
Sequencing Dna Rna Social
Beckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic test
MeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.
January 31, 2023
Sepsis Bacteria Social
Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease
The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.
January 31, 2023
Cardiac Heart Eeg Social
VieCure, Labcorp collaborate on clinical workflows, genomic testing
The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.
January 25, 2023
Dna Sequencing Social
Jumpcode Genomics enters PacBio’s Compatible Partner program
Jumpcode’s Single Cell RNA Boost Kit is compatible with PacBio’s Multiplexed Arrays Sequencing (MAS-Seq) for 10x Single Cell 3’ kit, which allows researchers to remove uninformative fragments from single-cell RNA sequencing libraries prior to sequencing.
January 12, 2023
Sequencing Dna Rna Social
Page 1 of 35
Next Page